Literature DB >> 6804309

Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.

G Realdi, A Alberti, M Rugge, A M Rigoli, F Tremolada, L Schivazappa, A Ruol.   

Abstract

The long-term outcome of non-A, non-B post-transfusion hepatitis was evaluated in 21 patients who developed the illness after open-heart surgery and could be followed thereafter up to five years. Histological chronic sequelae were documented in 13 patients, and consisted of chronic persistent hepatitis in one case, chronic lobular hepatitis in two and chronic active hepatitis in 10, five of whom also developed superimposed cirrhosis. Progression to these chronic states was in most cases symptomless, independently of the severity of liver lesions; one patient, however, died of gastrointestinal bleeding due to cirrhosis of the liver. During follow-up the biochemical pattern of chronic non-A, non-B hepatitis was unique, while striking fluctuations of transaminase levels. Liver histology proved essential to identify the severity of chronic liver lesions, as clinical and biochemical features were uniform and not indicative of it. Our results suggest that cirrhosis may develop, often with an asymptomatic course, in a significant number of patients who do not recover after acute post-transfusion non-A, non-B hepatitis.

Entities:  

Mesh:

Year:  1982        PMID: 6804309      PMCID: PMC1419734          DOI: 10.1136/gut.23.4.270

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Morphological criteria in viral hepatitis. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1971-02-13       Impact factor: 79.321

2.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

3.  The vocabulary of chronic hepatitis.

Authors:  H Popper; F Schaffner
Journal:  N Engl J Med       Date:  1971-05-20       Impact factor: 91.245

4.  Hepatitis "C" antigen in non-A, non-B post-transfusion hepatitis.

Authors:  R Shirachi; H Shiraishi; A Tateda; K Kikuchi; N Ishida
Journal:  Lancet       Date:  1978-10-21       Impact factor: 79.321

5.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

6.  Post-transfusion chronic liver disease.

Authors:  R L Koretz; S C Suffin; G L Gitnick
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

7.  Transmission of non-A, non-B hepatitis.

Authors:  J H Hoofnagle; R J Gerety; E Tabor; S M Feinstone; L F Barker; R H Purcell
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

8.  Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention.

Authors:  R G Knodell; M E Conrad; K G Ishak
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

9.  Transmissible agent in non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; P V Holland; H Popper
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

10.  Transmission of non-A, non-B hepatitis from man to chimpanzee.

Authors:  E Tabor; R J Gerety; J A Drucker; L B Seeff; J H Hoofnagle; D R Jackson; M April; L F Barker; G Pineda-Tamondong
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

View more
  35 in total

Review 1.  Parenterally acquired non-A non-B hepatitis ten years on: advances in diagnosis and therapy.

Authors:  M R Jacyna; H C Thomas
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 2.  Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Authors:  J Hayashi; S Kashiwagi
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

3.  Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.

Authors:  T Miyamura; I Saito; T Katayama; S Kikuchi; A Tateda; M Houghton; Q L Choo; G Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 4.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

Review 5.  Hepatitis C virus and transfusion transmitted liver disease: review.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

6.  Interferon as treatment for acute hepatitis C. A meta-analysis.

Authors:  C Cammà; P Almasio; A Craxì
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 7.  Patterns of progression: unpredictability and risk of decompensated cirrhosis.

Authors:  N C Tassopoulos
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

8.  Natural killer activity in patients with acute viral hepatitis.

Authors:  L Chemello; M Mondelli; F Bortolotti; E Schiavon; P Pontisso; A Alberti; E G Rondanelli; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

Review 9.  Non-A, non-B hepatitis: dead ends or new horizons?

Authors:  S A Iwarson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

Review 10.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.